Patel Chirag K.
SEC CIK 1738701 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals, Inc. | Pres, Co-CEO, Dir, 10% | 6.38M | $625.5K | — | 7 | 2021-12-15 | 2026-08-10 |
Most active insiders at AMRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shah Nikita | EVP | — | $4.14M |
| 2 | Daly Jason B. | EVP, CLO | — | $3.77M |
| 3 | Kiely John | Dir | — | $882.0K |
| 4 | Nark Ted C | Dir | — | $586.0K |
| 5 | Autor Deborah M. | Dir | — | $450.6K |
| 6 | George Jeffrey P. | Dir | — | — |
| 7 | Patel Tushar Bhikhubhai | 10% | — | — |
| 8 | Patel Chirag K. | Pres, Co-CEO, Dir | — | — |
| 9 | Patel Gautam | Dir | — | — |
| 10 | Patel Chintu | Co-CEO, Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-12 16:37 | 2026-08-10 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Chirag K. | Pres, Co-CEO, Dir | A - Grant | — | +6.38M | 6.38M | New | — |
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Patel Chirag K. | Pres, Co-CEO, Dir | M - OptEx | — | +886.5K | 1.64M | +118% | — |
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Patel Chirag K. | Pres, Co-CEO, Dir | F - Tax | $13.31 | -351.0K | 1.39M | -20% | -$4.67M |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Patel Chirag K. | Pres, Co-CEO, Dir | M - OptEx | — | +672.3K | 905.3K | +288% | — |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Patel Chirag K. | Pres, Co-CEO, Dir | F - Tax | $8.77 | -326.9K | 858.0K | -28% | -$2.87M |
| DI | 2023-11-08 | 2023-11-07 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Chirag K. | Pres, Co-CEO, Dir | J - Other | — | +21.27M | 21.27M | New | — |
| M | 2021-12-17 | 2021-12-15+ | AMRX | Amneal Pharmaceuticals, Inc. | Patel Chirag K. | Pres, Co-CEO, Dir, 10% | P - Purchase | $4.17 | +150.0K | 462.6K | +48% | +$625.5K |
Purchase Sale Sale after option exercise All abbreviations